The UK's health regulator has approved an antibody cocktail developed by Regeneron and Roche to prevent and treat Covid-19, it said on Friday, adding it was trying to roll it out to patients soon.
The Medicines and Healthcare products Regulatory Agency (MHRA) said the drug Ronapreve could help prevent infection, help resolve symptoms of severe Covid-19 infection and reduce the chances of hospitalisation.
"This treatment will be a significant addition to our armoury to tackle Covid-19," British health minister Sajid Javid said in a statement.
Ronapreve can be taken via injection or infusion. It binds tightly to the coronavirus at the lining of the respiratory system and prevents it from gaining access to cells of the respiratory system, the MHRA said.
Ronapreve belongs to a class of drugs called monoclonal antibodies which mimic natural antibodies produced by the body to fight off infections. The drug is not intended to be used as a substitute for vaccination, the MHRA said.
Last month Japan became the first country to approve Ronapreve to treat mild to moderate Covid-19 infections.
Gaza Now's Arabic channel has more than 300,000 followers on social media channel X, and a large following on Telegram
The iftar gathering served as a platform for people from diverse backgrounds to come together, socialise, and rejoice in the celebration
The monk was charged for comments made at a press conference held in March 2016.
The facility will provide greater access to residents from Liwa, Mirfa, Gayathi, Ruwais, Tarif from Western Region
High taxes, rising prices and rents, and fewer opportunities in those countries are prompting many to return to the Emirates, say experts
The UAE already has a 10-year Golden Visa programme for investors, entrepreneurs, property buyers and outstanding students since 2019
The anniversary coincides with the UAE’s decision to extend the ‘Year of Sustainability’